Rebaz M. Ali, “Pembrolizumab (Anti-PD-1) Immunotherapy in Malignant Pleural Mesothelioma: A Systematic Review of the Current Literature”, Barw Medical Journal, Jul. 2023, doi: 10.58742/bmj.v1i2.34.